BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23258429)

  • 1. Use of oral glucocorticoids and the risk of pulmonary embolism: a population-based case-control study.
    Stuijver DJF; Majoor CJ; van Zaane B; Souverein PC; de Boer A; Dekkers OM; Büller HR; Gerdes VEA
    Chest; 2013 May; 143(5):1337-1342. PubMed ID: 23258429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of glucocorticoids and risk of venous thromboembolism: a nationwide population-based case-control study.
    Johannesdottir SA; Horváth-Puhó E; Dekkers OM; Cannegieter SC; Jørgensen JO; Ehrenstein V; Vandenbroucke JP; Pedersen L; Sørensen HT
    JAMA Intern Med; 2013 May; 173(9):743-52. PubMed ID: 23546607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-steroidal anti-inflammatory drugs and risk of pulmonary embolism.
    Biere-Rafi S; Di Nisio M; Gerdes V; Porreca E; Souverein P; Boer A; Büller H; Kamphuisen P
    Pharmacoepidemiol Drug Saf; 2011 Jun; 20(6):635-42. PubMed ID: 21462279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study.
    Souverein PC; Berard A; Van Staa TP; Cooper C; Egberts AC; Leufkens HG; Walker BR
    Heart; 2004 Aug; 90(8):859-65. PubMed ID: 15253953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Glucocorticoids and Risk of Community-Acquired Staphylococcus aureus Bacteremia: A Population-Based Case-Control Study.
    Smit J; Kaasch AJ; Søgaard M; Thomsen RW; Nielsen H; Frøslev T; Schønheyder HC
    Mayo Clin Proc; 2016 Jul; 91(7):873-80. PubMed ID: 27289410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral glucocorticoid use and osteonecrosis in children and adults with chronic inflammatory diseases: a population-based cohort study.
    Horton DB; Haynes K; Denburg MR; Thacker MM; Rose CD; Putt ME; Leonard MB; Strom BL
    BMJ Open; 2017 Jul; 7(7):e016788. PubMed ID: 28733303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: A population-based cohort study.
    Pujades-Rodriguez M; Morgan AW; Cubbon RM; Wu J
    PLoS Med; 2020 Dec; 17(12):e1003432. PubMed ID: 33270649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of oral glucocorticoid use with an increased risk of acute pancreatitis: a population-based nested case-control study.
    Sadr-Azodi O; Mattsson F; Bexlius TS; Lindblad M; Lagergren J; Ljung R
    JAMA Intern Med; 2013 Mar; 173(6):444-9. PubMed ID: 23440105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of cumulative exposure to high-dose oral glucocorticoids on fracture risk in Denmark: a population-based case-control study.
    Amiche MA; Abtahi S; Driessen JHM; Vestergaard P; de Vries F; Cadarette SM; Burden AM
    Arch Osteoporos; 2018 Mar; 13(1):30. PubMed ID: 29552730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin treatment and the risk of recurrent pulmonary embolism.
    Biere-Rafi S; Hutten BA; Squizzato A; Ageno W; Souverein PC; de Boer A; Gerdes VE; Büller HR; Kamphuisen PW
    Eur Heart J; 2013 Jun; 34(24):1800-6. PubMed ID: 23396492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of systemic glucocorticoids and the risk of major osteoporotic fractures in patients with sarcoidosis.
    Oshagbemi OA; Driessen JHM; Pieffers A; Wouters EFM; Geusens P; Vestergaard P; van den Bergh J; Franssen FME; de Vries F
    Osteoporos Int; 2017 Oct; 28(10):2859-2866. PubMed ID: 28638981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral and inhaled corticosteroid use and risk of recurrent pulmonary embolism.
    Sneeboer MMS; Hutten BA; Majoor CJ; Bel EHD; Kamphuisen PW
    Thromb Res; 2016 Apr; 140():46-50. PubMed ID: 26897283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical indicators of adrenal insufficiency following discontinuation of oral glucocorticoid therapy: A Danish population-based self-controlled case series analysis.
    Laugesen K; Petersen I; Sørensen HT; Jørgensen JOL
    PLoS One; 2019; 14(2):e0212259. PubMed ID: 30779776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of ocular hypertension or open-angle glaucoma in elderly patients on oral glucocorticoids.
    Garbe E; LeLorier J; Boivin JF; Suissa S
    Lancet; 1997 Oct; 350(9083):979-82. PubMed ID: 9329512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study.
    Bernstein CN; Blanchard JF; Houston DS; Wajda A
    Thromb Haemost; 2001 Mar; 85(3):430-4. PubMed ID: 11307809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The natural course of hemodynamically stable pulmonary embolism: Clinical outcome and risk factors in a large prospective cohort study.
    Nijkeuter M; Söhne M; Tick LW; Kamphuisen PW; Kramer MH; Laterveer L; van Houten AA; Kruip MJ; Leebeek FW; Büller HR; Huisman MV;
    Chest; 2007 Feb; 131(2):517-23. PubMed ID: 17296656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical presentation of venous thromboembolism in inflammatory bowel disease.
    Papay P; Miehsler W; Tilg H; Petritsch W; Reinisch W; Mayer A; Haas T; Kaser A; Feichtenschlager T; Fuchssteiner H; Knoflach P; Vogelsang H; Platzer R; Tillinger W; Jaritz B; Schmid A; Blaha B; Dejaco C; Sobala A; Weltermann A; Eichinger S; Novacek G
    J Crohns Colitis; 2013 Oct; 7(9):723-9. PubMed ID: 23127785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory bowel disease increases the risks of deep vein thrombosis and pulmonary embolism in the hospitalized patients: a nationwide cohort study.
    Chung WS; Lin CL; Hsu WH; Kao CH
    Thromb Res; 2015 Mar; 135(3):492-6. PubMed ID: 25596768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose dependent increased mortality risk in COPD patients treated with oral glucocorticoids.
    Schols AM; Wesseling G; Kester AD; de Vries G; Mostert R; Slangen J; Wouters EF
    Eur Respir J; 2001 Mar; 17(3):337-42. PubMed ID: 11405508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose glucocorticoid therapy decreases risk for treatment-limiting infusion reaction to infliximab in patients with rheumatoid arthritis.
    Augustsson J; Eksborg S; Ernestam S; Gullström E; van Vollenhoven R
    Ann Rheum Dis; 2007 Nov; 66(11):1462-6. PubMed ID: 17502359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.